门静脉高压症

  • 网络Portal hypertension;PhT
门静脉高压症门静脉高压症
  1. 结论对肝功能尚好的门静脉高压症病人实施预防性联合手术有助于提高其生活质量。

    Conclusion Combined operation for the PHT patients with good liver function is attributed to the improvement of the life quality .

  2. 方法5例合并甲亢的门静脉高压症病人经积极的术前准备后均行脾切除加贲门周围血管离断术。

    Methods 5 patients with hyperthyroidism complicated PHT were performed with splenectomy plus pericardial devascularization after preoperative management , and the experience of pre and postoperative management was summarized .

  3. 门静脉高压症大鼠肠系膜组织内皮素B受体表达的变化

    Expression of Endothelin-B Receptor in the Mesentery of Portal Hypertension Rats

  4. 肝硬化门静脉高压症的超声与CT对照观察

    Diagnosis of Liver Cirrhosis with Portal Hypertension : Comparison between Ultrasound and Computer Tomography

  5. 局部肾素与血管紧张素原mRNA在肝硬化门静脉高压症患者中的表达及其意义

    Expression of local renin and angiotensinogen mRNA in cirrhotic portal hypertensive patients

  6. 前列腺素E1治疗肝硬化门静脉高压症46例

    Clinical analysis on Treating 46 cases of cirrhotic portal hypertention with prostaglandin E 1

  7. 目的探讨脾静脉阻塞所致左侧门静脉高压症的多层螺旋CT表现及其临床特征。

    ObjectiveTo analyze the multi-slice CT appearances and clinical features of left-sided portal hypertension ( LPH ) .

  8. 门静脉高压症患者巨脾组织CD细胞的变化

    The changes of CD cells in splenic tissue in patients with portal hypertension

  9. 局部血管紧张素原mRNA的表达与核因子-κB的活化在门静脉高压症性血管病变中的意义

    Expression of local angiotensinogen mRNA and activation of local nuclear factor - κ B in vasculopathy of portal hypertension

  10. 核因子-κB的活化与肿瘤坏死因子-αmRNA的表达在门静脉高压症性血管病变中的作用

    Activation of nuclear factor - κ B and expression of TNF - α mRNA in vasculopathy of portal hypertension

  11. 目的超声与CT对照在肝硬化门静脉高压症中的诊断应用。

    Objective To evaluate the diagnostic value in liver cirrhosis with portal hypertension between ultrasound and computer tomography ( CT ) .

  12. ER在门静脉高压症肝脏组织中的表达及其临床意义

    Estrogen Receptor Expression and Clinical Significance in Liver Tissue of Patients With Portal Hypertension

  13. 目的了解H1和H2受体在肝硬变门静脉高压症大鼠和病人肝组织中的变化。

    Objective To know the sensity of H1 and H2 receptors on hepatic tissues of cir-rhotic rats and cirrhotic patients with portal hypertension .

  14. 目的:探讨肝功能ChildC级的门静脉高压症合并上消化道出血手术治疗的可行性。

    Objective : To explore the possibility of operative treatment of patients with portal hypertension and liver function Child grade C with hemorrhage of upper digestive tract .

  15. CTA在门静脉高压症治疗中的应用研究

    Applied Research of CT Angiography in the Treatment of Portal Hypertension

  16. PDGFmRNA及TGF-β在门静脉高压症病人内脏血管重构中的表达及意义

    Expression of PDGF mRNA and TGF - β in splenic vascular remodeling in portal hypertensive patients

  17. 脾脏动、静脉组织基质Gla蛋白mRNA的表达在门静脉高压症性血管病变中的意义

    The role of expression of matrix Gla protein mRNA in vasculopathy of portal hypertension

  18. 门静脉高压症脾功能亢进患者脾巨噬细胞Toll样受体4的表达及其意义

    Expression and significance of Toll-like receptor 4 of splenic macrophage in patients with hypersplenism due to portal hypertension

  19. 缬沙坦对肝硬化门静脉高压症患者ET、NO、TNF-α浓度的影响及意义

    Effects of valsartan on ET , NO and TNF - α in hepatic cirrhosis patients with portal hypertension and its significance

  20. 随机留15只作为正常对照组(NC),其余大鼠先建立可复性肝前性门静脉高压症模型。

    15 rats were taken randomly as normal control group ( NC ), The recoverable prehepatic portal hypertensive model were induced on other rats .

  21. 目的探讨胃冠状静脉TH胶栓塞加脾切除术治疗门静脉高压症食管胃底曲张静脉破裂出血的效果。

    Objective To study the therapeutic effect of stomach coronary vein TH glue embolism plus lienectomy in the treatment of portal hypertension .

  22. 自体脾移植及食管横断吻合术治疗肝硬化门静脉高压症移植脾的MRA远期观察

    Long-term follow-up by 3D-DCE MRA in patients with portal hypertension after splenic autotransplantation plus cardia-esophageal devascularization

  23. 局部AngⅡ水平与ERK的活化在人门静脉高压症脾静脉血管病变中的作用

    Local Ang ⅱ Levels and Extracellular Signal-Regulated Kinase Activation in Splenic Vein Vasculopathy in Portal Hypertension

  24. 细胞外信号调节激酶(1/2)及c-fos在门静脉高压症患者脾静脉壁的表达及意义

    Expression of ERK _ ( 1 / 2 ) and c-fos in splenic vein of the patients with portal hypertension

  25. Caveolin-1与内皮型一氧化氮合成酶在门静脉高压症性血管病变中的表达

    Caveolin-1 and endothelial nitric oxide synthase expressions in vasculopathy of portal hypertension

  26. 肝门静脉高压症(PHT)血液动力学研究进展

    Progress in the Research on Hemodynamics of Portal Hypertension

  27. 结论单一类型钾离子通道开放并不是门静脉高压症鼠动脉对NE低反应的主要原因。

    Conclusion Opening of a single type of potassium channels is not the major cause of reduced vascular NE responsiveness in portal hypertension .

  28. TIPS、改良Sugiura术和TIPS加改良Sugiura术治疗门静脉高压症的疗效观察

    Comparison of TIPS , a modified Sugiura procedure and TIPS plus a modified Sugiura procedure for portal hypertension

  29. 目的探讨纤维蛋白封闭剂(FS)在晚期血吸虫病性门静脉高压症手术治疗中的应用价值。

    Objective To study the application effect of fibrin sealant ( FS ) during operation for late-stage portal hypertension caused by schistosomiasis .

  30. 方法采用α氰基丙烯酸正辛脂(含显影剂的TH胶)对106例门静脉高压症引起食管胃底静脉曲张的患者行胃冠状静脉栓塞加脾切除术。

    Methods 106 cases of portal hypertension with esophago-fundus of stomach varicosis were treated by using α - cyanogen acrylic ( omni-developer with TH glue ) embolism plus lienectomy .